TY - JOUR AU - Schou, M. AU - Steiger, C. AU - Varrone, A. AU - Guilloteau, D. AU - Halldin, C. PY - 2009 DA - 2009// TI - Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter JO - Bioorg Med Chem Lett VL - 19 UR - https://doi.org/10.1016/j.bmcl.2009.06.032 DO - 10.1016/j.bmcl.2009.06.032 ID - Schou2009 ER - TY - JOUR AU - Varrone, A. AU - Steiger, C. AU - Schou, M. PY - 2009 DA - 2009// TI - In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand JO - Synapse. VL - 63 UR - https://doi.org/10.1002/syn.20670 DO - 10.1002/syn.20670 ID - Varrone2009 ER - TY - JOUR AU - Varrone, A. AU - Toth, M. AU - Steiger, C. PY - 2011 DA - 2011// JO - J Nucl Med VL - 52 UR - https://doi.org/10.2967/jnumed.110.077651 DO - 10.2967/jnumed.110.077651 ID - Varrone2011 ER - TY - JOUR AU - Varrone, A. AU - Gulyás, B. AU - Takano, A. AU - Stabin, M. G. AU - Jonsson, C. AU - Halldin, C. PY - 2012 DA - 2012// TI - Simplified quantification and whole-body distribution of 18F-FE-PE2I in nonhuman primates: prediction for human studies JO - Nucl Med Biol VL - 39 UR - https://doi.org/10.1016/j.nucmedbio.2011.08.004 DO - 10.1016/j.nucmedbio.2011.08.004 ID - Varrone2012 ER - TY - JOUR AU - Sasaki, T. AU - Ito, H. AU - Kimura, Y. PY - 2012 DA - 2012// TI - Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I JO - J Nucl Med VL - 53 UR - https://doi.org/10.2967/jnumed.111.101626 DO - 10.2967/jnumed.111.101626 ID - Sasaki2012 ER - TY - JOUR AU - Fazio, P. AU - Svenningsson, P. AU - Forsberg, A. PY - 2015 DA - 2015// TI - Quantitative analysis of 18F-(E)-N-(3-iodoprop-2-enyl)-2-carbofluoroethoxy-3-(4′-methyl-phenyl) nortropane binding to the dopamine transporter in Parkinson disease JO - J Nucl Med VL - 56 UR - https://doi.org/10.2967/jnumed.114.152421 DO - 10.2967/jnumed.114.152421 ID - Fazio2015 ER - TY - JOUR AU - Sonni, I. AU - Fazio, P. AU - Schain, M. PY - 2016 DA - 2016// TI - Optimal acquisition time window and simplified quantification of dopamine transporter availability using 18F-FE-PE2I in healthy controls and Parkinson’s disease patients JO - J Nucl Med VL - 57 UR - https://doi.org/10.2967/jnumed.115.171231 DO - 10.2967/jnumed.115.171231 ID - Sonni2016 ER - TY - JOUR AU - Lizana, H. AU - Johansson, L. AU - Axelsson, J. PY - 2018 DA - 2018// TI - Whole-body biodistribution and dosimetry of the dopamine transporter radioligand 18fF-Fe-PE2I in human subjects JO - J Nucl Med VL - 59 UR - https://doi.org/10.2967/jnumed.117.197186 DO - 10.2967/jnumed.117.197186 ID - Lizana2018 ER - TY - JOUR AU - Fazio, P. AU - Svenningsson, P. AU - Cselényi, Z. AU - Halldin, C. AU - Farde, L. AU - Varrone, A. PY - 2018 DA - 2018// TI - Nigrostriatal dopamine transporter availability in early Parkinson’s disease JO - Mov Disord VL - 33 UR - https://doi.org/10.1002/mds.27316 DO - 10.1002/mds.27316 ID - Fazio2018 ER - TY - JOUR AU - Kordower, J. H. AU - Olanow, C. W. AU - Dodiya, H. B. PY - 2013 DA - 2013// TI - Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease JO - Brain VL - 136 UR - https://doi.org/10.1093/brain/awt192 DO - 10.1093/brain/awt192 ID - Kordower2013 ER - TY - JOUR AU - Karimi, M. AU - Tian, L. AU - Brown, C. A. PY - 2013 DA - 2013// TI - Validation of nigrostriatal positron emission tomography measures: critical limits JO - Ann Neurol VL - 73 UR - https://doi.org/10.1002/ana.23798 DO - 10.1002/ana.23798 ID - Karimi2013 ER - TY - JOUR AU - Jakobsson Mo, S. AU - Axelsson, J. AU - Jonasson, L. PY - 2018 DA - 2018// TI - Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT-a clinical comparison JO - EJNMMI Res VL - 8 UR - https://doi.org/10.1186/s13550-018-0450-0 DO - 10.1186/s13550-018-0450-0 ID - Jakobsson Mo2018 ER - TY - JOUR AU - Suzuki, M. AU - Ito, H. AU - Kodaka, F. PY - 2014 DA - 2014// TI - Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[b-11C]DOPA and [18F]FE-PE2I in humans JO - Nucl Med Commun VL - 35 UR - https://doi.org/10.1097/MNM.0000000000000052 DO - 10.1097/MNM.0000000000000052 ID - Suzuki2014 ER - TY - JOUR AU - Tziortzi, A. C. AU - Haber, S. N. AU - Searle, G. E. PY - 2014 DA - 2014// TI - Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomography JO - Cereb Cortex VL - 24 UR - https://doi.org/10.1093/cercor/bhs397 DO - 10.1093/cercor/bhs397 ID - Tziortzi2014 ER - TY - JOUR AU - Cervenka, S. AU - Bäckman, L. AU - Cselényi, Z. AU - Halldin, C. AU - Farde, L. PY - 2008 DA - 2008// TI - Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum JO - Neuroimage. VL - 40 UR - https://doi.org/10.1016/j.neuroimage.2007.12.063 DO - 10.1016/j.neuroimage.2007.12.063 ID - Cervenka2008 ER - TY - JOUR AU - Kübler, D. AU - Schroll, H. AU - Buchert, R. AU - Kühn, A. A. PY - 2017 DA - 2017// TI - Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson’s patients JO - J Neural Transm VL - 124 UR - https://doi.org/10.1007/s00702-017-1747-2 DO - 10.1007/s00702-017-1747-2 ID - Kübler2017 ER - TY - JOUR AU - Martín-Bastida, A. AU - Lao-Kaim, N. P. AU - Roussakis, A. A. PY - 2019 DA - 2019// TI - Relationship between neuromelanin and dopamine terminals within the Parkinson’s nigrostriatal system JO - Brain. VL - 142 UR - https://doi.org/10.1093/brain/awz120 DO - 10.1093/brain/awz120 ID - Martín-Bastida2019 ER - TY - JOUR AU - Nero, H. AU - Benka Wallén, M. AU - Franzén, E. AU - Conradsson, D. AU - Ståhle, A. AU - Hagströmer, M. PY - 2016 DA - 2016// TI - Objectively assessed physical activity and its association with balance, physical function and dyskinesia in Parkinson’s disease JO - J Parkinsons Dis VL - 6 UR - https://doi.org/10.3233/JPD-160826 DO - 10.3233/JPD-160826 ID - Nero2016 ER - TY - JOUR AU - Benka Wallén, M. AU - Franzén, E. AU - Nero, H. AU - Hagströmer, M. PY - 2015 DA - 2015// TI - Levels and patterns of physical activity and sedentary behavior in elderly people with mild to moderate Parkinson disease JO - Phys Ther VL - 95 UR - https://doi.org/10.2522/ptj.20140374 DO - 10.2522/ptj.20140374 ID - Benka Wallén2015 ER - TY - JOUR AU - Choi, L. AU - Liu, Z. AU - Matthews, C. E. PY - 2011 DA - 2011// TI - Validation of accelerometer wear and nonwear time classification algorithm JO - Med Sci Sport Exer VL - 43 UR - https://doi.org/10.1249/MSS.0b013e3181ed61a3 DO - 10.1249/MSS.0b013e3181ed61a3 ID - Choi2011 ER - TY - JOUR AU - Stepanov, V. AU - Krasikova, R. AU - Raus, L. AU - Loog, O. AU - Hiltunen, J. AU - Halldin, C. PY - 2012 DA - 2012// TI - An efficient one-step radiosynthesis of [18F]Fe-PE2I, a PET radioligand for imaging of dopamine transporters JO - J Label Compd Radiopharm VL - 55 UR - https://doi.org/10.1002/jlcr.2927 DO - 10.1002/jlcr.2927 ID - Stepanov2012 ER - TY - JOUR AU - Varrone, A. AU - Sjöholm, N. AU - Eriksson, L. AU - Gulyás, B. AU - Halldin, C. AU - Farde, L. PY - 2009 DA - 2009// TI - Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT JO - Eur J Nucl Med Mol Imaging VL - 36 UR - https://doi.org/10.1007/s00259-009-1156-3 DO - 10.1007/s00259-009-1156-3 ID - Varrone2009 ER - TY - JOUR AU - Schain, M. AU - Tóth, M. AU - Cselényi, Z. PY - 2012 DA - 2012// TI - Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems JO - Neuroimage VL - 60 UR - https://doi.org/10.1016/j.neuroimage.2011.12.047 DO - 10.1016/j.neuroimage.2011.12.047 ID - Schain2012 ER - TY - JOUR AU - Cselényi, Z. AU - Olsson, H. AU - Halldin, C. AU - Gulyas, B. AU - Farde, L. PY - 2006 DA - 2006// TI - A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635 JO - Neuroimage. VL - 32 UR - https://doi.org/10.1016/j.neuroimage.2006.02.053 DO - 10.1016/j.neuroimage.2006.02.053 ID - Cselényi2006 ER - TY - JOUR AU - Weir, J. P. PY - 2005 DA - 2005// TI - Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM JO - J Strength Cond Res VL - 19 ID - Weir2005 ER - TY - JOUR AU - Baumgartner, R. AU - Joshi, A. AU - Feng, D. AU - Zanderigo, F. AU - Ogden, T. PY - 2018 DA - 2018// TI - Statistical evaluation of test-retest studies in PET brain imaging JO - EJNMMI Res VL - 8 UR - https://doi.org/10.1186/s13550-018-0366-8 DO - 10.1186/s13550-018-0366-8 ID - Baumgartner2018 ER - TY - JOUR AU - Matheson, G. J. PY - 2019 DA - 2019// TI - We need to talk about reliability: making better use of test-retest studies for study design and interpretation JO - PeerJ VL - 7 UR - https://doi.org/10.7717/peerj.6918 DO - 10.7717/peerj.6918 ID - Matheson2019 ER - TY - STD TI - Portney LG, Watkins MP. Foundations of clinical research: applications to practice. FA Davis. 2015. ID - ref28 ER - TY - BOOK AU - Nunnally, J. C. PY - 1978 DA - 1978// TI - Psychometric theory PB - McGraw-Hill CY - New York ID - Nunnally1978 ER - TY - JOUR AU - Hirvonen, J. AU - Johansson, J. AU - Teräs, M. PY - 2008 DA - 2008// TI - Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and 11C-PE2I: quantitative modeling and test-retest reproducibility JO - J Cerebral Blood Flow Metabol VL - 28 UR - https://doi.org/10.1038/sj.jcbfm.9600607 DO - 10.1038/sj.jcbfm.9600607 ID - Hirvonen2008 ER - TY - JOUR AU - Nurmi, E. AU - Bergman, J. AU - Eskola, O. PY - 2000 DA - 2000// TI - Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study JO - J Cereb Blood Flow Metab VL - 20 UR - https://doi.org/10.1097/00004647-200011000-00010 DO - 10.1097/00004647-200011000-00010 ID - Nurmi2000 ER - TY - JOUR AU - Seibyl, J. P. AU - Marek, K. AU - Sheff, K. PY - 1997 DA - 1997// TI - Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson’s patients JO - J Nucl Med VL - 38 ID - Seibyl1997 ER - TY - JOUR AU - Booij, J. AU - Habraken, J. B. AU - Bergmans, P. PY - 1998 DA - 1998// TI - Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson’s disease JO - J Nucl Med VL - 39 ID - Booij1998 ER - TY - JOUR AU - Tsuchida, T. AU - Ballinger, J. R. AU - Vines, D. PY - 2004 DA - 2004// TI - Reproducibility of dopamine transporter density measured with123I-FPCIT SPECT in normal control and Parkinson’s disease patients JO - Ann Nucl Med VL - 18 UR - https://doi.org/10.1007/BF02984583 DO - 10.1007/BF02984583 ID - Tsuchida2004 ER - TY - JOUR AU - Ziebell, M. AU - Thomsen, G. AU - Knudsen, G. M. PY - 2007 DA - 2007// TI - Reproducibility of 123I-PE2I binding to dopamine transporters with SPECT JO - EJNMMI. VL - 34 ID - Ziebell2007 ER - TY - JOUR AU - Winogrodzka, A. AU - Bergmans, P. AU - Booij, J. AU - Royen, E. A. AU - Stoof, J. C. AU - Wolters, E. C. PY - 2003 DA - 2003// TI - [123I]β-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson’s disease JO - J Neurol Neurosurg Psychiatry VL - 74 UR - https://doi.org/10.1136/jnnp.74.3.294 DO - 10.1136/jnnp.74.3.294 ID - Winogrodzka2003 ER - TY - JOUR AU - Sung, C. AU - Lee, J. H. AU - Oh, J. S. PY - 2017 DA - 2017// TI - Longitudinal decline of striatal subregional [18F]FP-CIT uptake in Parkinson’s disease JO - Nucl Med Mol Imaging VL - 51 UR - https://doi.org/10.1007/s13139-017-0481-x DO - 10.1007/s13139-017-0481-x ID - Sung2017 ER -